International Investing

Bragging About My Own Book

Big Cannabis took a step back this week as investors ponder the ultimate future of the largest cultivators. In a world where Aurora Cannabis Inc. (NYSE:ACB) needs to sell $125 million in stock to survive, size is clearly not the key to success.

But on my end of the industry, we’re having a lot of fun. Two of the stocks in my IPO Edge portfolio are still ringing triple-digit-percentage bells.

While I normally keep those stocks secret to reserve the best opportunities for subscribers, I’m going to brag a little today. The elite have already gotten a taste. Now it’s your turn to take a look.

Juva Life Inc. (OTC:JUVAF) is tiny, not even a fraction of the size of ACB or the other giants. We were here at $0.75. You can do that math yourself.

The allure is that unlike the giants, JUVAF has a blue-sky future ahead of it. The business model goes a lot deeper than simply growing a lot of plant product.

Management has learned from the giants’ mistakes. They aren’t trying to become a $10 billion unicorn on their own. But if they get an acquisition offer for $2 billion down the road, shareholders will cheer.

And while HempFusion Wellness Inc. (TSX:CBD.U) is only available in Canada, those who caught the opening-day shares a few weeks ago are already applauding. This isn’t cannabis. It isn’t even growing hemp.

We’re here for value-added consumer products enhanced with hemp derivatives. That’s the true “Cannabis 2.0” story Wall Street was promised years ago.

If you’re tired of generic cultivators, go small. And when I think of great things in small packages, IPO Edge is the place.

Exclusive Seven Tips to Day-Trade with a Signal

Hilary Kramer

Hilary Kramer is an investment analyst and portfolio manager with 30 years of experience on Wall Street. The Financial Times describes Ms. Kramer as “A one-woman financial investment powerhouse” and The Economist distinguishes her as “one of the best-known investors in America”. Ms. Kramer is often quoted in publications such as the Wall Street Journal, New York Post, Bloomberg, and Reuters. She is a frequent guest commentator on CNBC, CBS, Fox News and Bloomberg, providing investment insight and economic analysis. Ms. Kramer was an analyst and investment banker at Morgan Stanley and Lehman Brothers. Ms. Kramer founded and ran a long-short hedge fund and has been chief investment officer overseeing debt and equity portfolios. Since 2010, Ms. Kramer’s financial publications have provided stock analysis and investment advice to her subscribers. Her products include GameChangers, Value Authority, High Octane Trader, Triple-Digit Trader, 2-Day Trader, IPO Edge and Inner Circle. Ms. Kramer, a Certified Fraud Examiner, has also testified as an expert in investment suitability, risk management, compliance, executive compensation, and corporate governance. Ms. Kramer received her MBA from the Wharton School at the University of Pennsylvania and her BA with honors from Wellesley College. Ms. Kramer has provided testimony regarding investment policy to the U.S. Senate and is a frequent speaker on the markets, portfolio management and securities fraud and compliance. Ms. Kramer is also the author of “Ahead of the Curve” (Simon & Schuster 2007) and “The Little Book of Big Profits from Small Stocks” (Wiley 2012).